International organizations are sequencing thousands of cancer genomes to find novel genetic changes, and individuals with money are paying for genomewide association studies in hopes of preventing diseases to which they are predisposed. ​

Do you envision that within the next few years all newborns would have their genome sequenced? And why? And who would pay for it? Would the benefit be enough for governments and insurance companies to pay for it?

In a previous issue of Clinical Chemistry, experts discussed genome sequencing in this Q&A​ (free to access). We’d like to get your views on the topic.
